

Rhode Island will also receive 67,000 30-pill bottles of the treatment drug Suboxone in various doses over the next 10 years at no cost, bringing the combined settlement value up to approximately $107 million to combat the opioid epidemic. The agreements resolve claims brought by the Rhode Island Attorney General Office for the companies’ roles in helping to fuel the opioid epidemic.
Over the past year, the Rhode Island Attorney General negotiated a total of more than $250 million for opioid treatment, rescue, prevention, and recovery in Rhode Island. The most recent opioid settlement agreement also resolves Rhode Island’s claims against the last remaining opioid defendant in Rhode Island’s principal opioid litigation.
The opioid settlement specifics:
- Teva and Allergan will pay Rhode Island a combined $28.5 million over 13 years: $21 million from Teva and $7.5 million from Allergan.
- Municipalities will have the same opportunity to share in this recovery under the Memorandum of Understanding between Rhode Island and cities and towns, which provides that 20% of the cash recoveries will go to cities and towns that join the agreement.
- Payments are front-loaded to ensure monetary relief to Rhode Island as quickly as possible:
- A total of $12 million will be paid within 60 days of the settlement.
- Rhode Island will receive more than half of its cash recovery from Teva – $13 million – within one year of the settlement.
- Rhode Island will receive its full recovery from Allergan within six years, at $1.25 million per year.
- Cities and towns will have an opportunity to receive their share of funds upfront by joining the settlement within 60 days.
- Teva has also committed to supply Rhode Island with supplies of Naloxone and Suboxone that are sufficient to meet the State’s projected needs for the next 10 years, according to Rhode Island health officials.
- Teva will supply 50,000 kits of Naloxone (100,000 nasal sprays) per year for 10 years, valued at $62.5 million. Naloxone is a lifesaving intervention that can reverse the often-fatal effects of an overdose.
- Teva will supply Suboxone valued at $16 million over 10 years. Suboxone is a medication used to treat opioid use disorder.
The Rhode Island Attorney General stated with regard to the settlement: “While no amount of money will ever be enough to undo the harm suffered by Rhode Islanders throughout the ongoing opioid epidemic, these additional recoveries will further support public health efforts to respond to the challenges brought on by this epidemic, which have grown much worse during the Covid-19 pandemic. And now, with the agreement of Teva to supply the state with enough Naloxone to meet the projected demand, at no cost for the next 10 years, we can use these hard-gained monetary recoveries for other purposes. City and town leaders have been important partners in this litigation, and I look forward to working with them to deliver these additional resources to the people they serve.”
If you or a loved one may have been injured as a result of medical malpractice in Rhode Island or in another U.S. state, you should promptly find a Rhode Island medical malpractice attorney, or a medical malpractice attorney in your state, who may investigate your medical malpractice claim for you and represent you and your loved one in a medical malpractice case, if appropriate.
Click here to visit our website or call us toll-free in the United States at 800-295-3959 to find medical malpractice lawyers in your state who may assist you.
Turn to us when you don’t know where to turn.
